Volume 18, Number 10—October 2012
Dispatch
Hepatitis E Virus Seroprevalence among Adults, Germany
Table 2
Univariable survey-weighted logistic regression estimates of seroprevalence of hepatitis E virus IgG, by age, sex, and location of residence, Germany, 2008–2011*
| Characteristic | Seroprevalence, % (95% CI) |
|---|---|
| Total | 16.8 (15.6–17.9) |
| Age group, y | |
|
18–19 |
5.3 (2.5–11.1) |
|
20–29 |
6.6 (4.8–9.2) |
|
30–39 |
8.0 (5.8–10.8) |
|
40–49 |
16.9 (14.3–19.9) |
|
50–59 |
22.6 (19.7–25.7) |
|
60–69 |
26.1 (23.0–29.4) |
|
70–79 |
23.8 (20.4–27.5) |
| Sex | |
|
M |
16.8 (15.2–18.5) |
|
F |
16.7 (15.2–18.5) |
| Place of residence (north–south) | |
|
Northern states |
15.5 (13.5–17.6) |
|
Middle states |
16.6 (14.8–18.6) |
|
Southern states |
17.9 (15.8–20.1) |
| Place of residence (east-west) | |
|
Western states |
16.6 (15.2–18.0) |
|
Eastern states |
17.6 (15.6–19.7) |
| Population of municipality | |
|
<5,000 |
17.9 (15.3–20.8) |
|
5,000–<20,000 |
17.5 (15.2–20.1) |
|
20,000–<100,000 |
14.4 (12.4–16.6) |
|
>100,000 |
17.7 (15.7–20.0) |
*n = 4,352.
1These authors contributed equally to this article.
Page created: September 14, 2012
Page updated: September 14, 2012
Page reviewed: September 14, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.